Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Obesity
Gastroparesis
Interventions
DRUG:
GLP-1 medication
Sponsor
The Cleveland Clinic